Is Oracle (ORCL) a Buy as Wall Street Analysts Look Optimistic?

11.02.25 15:30 Uhr

Werte in diesem Artikel
Aktien

171,26 EUR -2,02 EUR -1,17%

Indizes

PKT PKT

19.680,6 PKT -33,6 PKT -0,17%

2.965,9 PKT 9,1 PKT 0,31%

6.073,2 PKT 6,8 PKT 0,11%

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Oracle (ORCL) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Oracle currently has an average brokerage recommendation (ABR) of 1.76, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 34 brokerage firms. An ABR of 1.76 approximates between Strong Buy and Buy.Of the 34 recommendations that derive the current ABR, 22 are Strong Buy, representing 64.7% of all recommendations.Brokerage Recommendation Trends for ORCLCheck price target & stock forecast for Oracle here>>>While the ABR calls for buying Oracle, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.Is ORCL a Good Investment?Looking at the earnings estimate revisions for Oracle, the Zacks Consensus Estimate for the current year has declined 0.1% over the past month to $6.22.Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Oracle. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, it could be wise to take the Buy-equivalent ABR for Oracle with a grain of salt.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oracle Corporation (ORCL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Oracle

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Oracle

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Oracle Corp.

Wer­bung

Analysen zu Oracle Corp.

DatumRatingAnalyst
27.01.2025Oracle BuyJefferies & Company Inc.
03.01.2025Oracle Sector PerformRBC Capital Markets
10.12.2024Oracle HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.12.2024Oracle Sector PerformRBC Capital Markets
10.12.2024Oracle NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
27.01.2025Oracle BuyJefferies & Company Inc.
10.12.2024Oracle BuyUBS AG
10.12.2024Oracle BuyJefferies & Company Inc.
05.12.2024Oracle BuyJefferies & Company Inc.
30.09.2024Oracle KaufenDZ BANK
DatumRatingAnalyst
03.01.2025Oracle Sector PerformRBC Capital Markets
10.12.2024Oracle HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.12.2024Oracle Sector PerformRBC Capital Markets
10.12.2024Oracle NeutralJP Morgan Chase & Co.
23.10.2024Oracle Sector PerformRBC Capital Markets
DatumRatingAnalyst
13.12.2022Oracle SellGoldman Sachs Group Inc.
21.10.2022Oracle SellGoldman Sachs Group Inc.
19.03.2019Oracle VerkaufenDZ BANK
17.09.2015Oracle SellJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.01.2015Oracle SellJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Oracle Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"